نتائج البحث - "Bart A. van de Wiel"

1

Talimogene laherparepvec monotherapy for head and neck melanoma patients

المؤلفون: Viola, Franke, Emma H A, Stahlie, Willem M C, Klop, Charlotte L, Zuur, Danique M S, Berger, Bernies, van der Hiel, Bart A, van de Wiel, Michel W J M, Wouters, Winan J, van Houdt, Alexander C J, van Akkooi

المصدر: Melanoma Research. 33:66-70

مصطلحات موضوعية: Cancer Research, Oncology, Dermatology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435776695b7927730672cd3cf881b871Test
https://doi.org/10.1097/cmr.0000000000000866Test

2

Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma

المؤلفون: Bart A. van de Wiel, Judith M. Versluis, Robyn P. M. Saw, Sydney Ch'ng, C. Blank, Bastian Schilling, Irene L.M. Reijers, Richard A. Scolyer, Georgina V. Long, Michel W.J.M. Wouters, Alexander C.J. van Akkooi, Elisa A. Rozeman, Alexander M. Menzies

المصدر: European Journal of Cancer. 148:51-57

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Ipilimumab, Metastasis, Neoplasms, Multiple Primary, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Melanoma, Lymph node, Neoadjuvant therapy, Aged, Neoplasm Staging, Retrospective Studies, business.industry, Middle Aged, medicine.disease, Neoadjuvant Therapy, Survival Rate, Clinical trial, Nivolumab, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Lymphadenectomy, Neoplasm Recurrence, Local, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0cd6cfcc041a55a4244871ca4c62202Test
https://doi.org/10.1016/j.ejca.2021.02.012Test

3

Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients

المؤلفون: Emma H.A. Stahlie, Evalyn E.A.P. Mulder, Sophie Reijers, Sara Balduzzi, Charlotte L. Zuur, Willem M.C. Klop, Bernies van der Hiel, Bart A. Van de Wiel, Michel W.J.M. Wouters, Yvonne M. Schrage, Winan J. van Houdt, Dirk J. Grunhagen, Alexander C.J. van Akkooi

المساهمون: Surgery, Medical Oncology

المصدر: Critical Reviews in Oncology/Hematology, 175. ELSEVIER SCIENCE INC
Critical Reviews in Oncology/Hematology, 175:103705. Elsevier Ireland Ltd

مصطلحات موضوعية: Oncolytic Virotherapy, Biological Products, T-VEC, Skin Neoplasms, Oncology, Humans, Metastatic, Herpesvirus 1, Human, Hematology, Immunotherapy, Melanoma

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afda418f16f959e55733a43646188c96Test
https://doi.org/10.1016/j.critrevonc.2022.103705Test

4

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

المصدر: Nature Medicine. 27:301-309

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::826ffd3ff8235e1e6c027f5367069a0cTest
https://doi.org/10.1038/s41591-020-01188-3Test

5

SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment

المؤلفون: Alexander C.J. van Akkooi, Paweł Teterycz, Asier Antoranz, Willeke A. M. Blokx, Francesco Delogu, Bart A. van de Wiel, Senada Koljenović, Martin G. Cook, Piotr Rutkowski, Francesca Maria Bosisio, Daniela Massi, Anna Szumera-Ciećkiewicz, Léon C van Kempen

المساهمون: Pathology

المصدر: European Journal of Cancer, 137, 175-182. ELSEVIER SCI LTD
European Journal of Cancer, 137, 175-182. Elsevier Ltd.

مصطلحات موضوعية: Male, EXPRESSION, 0301 basic medicine, Cancer Research, Pathology, medicine.medical_specialty, Sentinel lymph node, DIAGNOSIS, Metastasis, MALIGNANT-MELANOMA, 03 medical and health sciences, 0302 clinical medicine, True prognostic value, Biopsy, SOX10, medicine, Humans, CELL, IMMUNOHISTOCHEMISTRY, Neoplasm Metastasis, Melanoma, Lymph node, medicine.diagnostic_test, SOXE Transcription Factors, business.industry, S100 Proteins, Myoepithelial cell, Cancer, medicine.disease, TUMORS, FAMILY, WAARDENBURG-SYNDROME, 030104 developmental biology, medicine.anatomical_structure, Oncology, MARKER, 030220 oncology & carcinogenesis, embryonic structures, Female, Lymph, pS100, business, NEOPLASMS

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139dd51d040f0c1b9e2a2399a372723aTest
https://doi.org/10.1016/j.ejca.2020.06.037Test

6

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

المؤلفون: Bart A. van de Wiel, Michel W.J.M. Wouters, Winan J. van Houdt, Alexander C.J. van Akkooi, Max F. Madu, Katarzyna Jóźwiak, Viola Franke, Willem M.C. Klop

المساهمون: Plastic, Reconstructive and Hand Surgery

المصدر: Melanoma research, 30(2), 185-192. Lippincott Williams and Wilkins

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25add3f1123d0bc9380a77b423692ef1Test
http://www.scopus.com/inward/record.url?scp=85081943540&partnerID=8YFLogxKTest

7

IMPemBra, a phase 2 study comparing pembrolizumab with intermittent/short‐term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation: Three-year survival data and translational analyses

المؤلفون: Elisa A. Rozeman, Judith M. Versluis, Esmée P Hoefsmit, Petros Dimitriadis, Lindsay G. Grijpink-Ongering, Karolina Sikorska, Bart A. van de Wiel, Birthe C Heeres, Claudi Flohil, Pia Kvistborg, Daan van den Broek, Annegien Broeks, Jan Willem de Groot, Sofie Wilgenhof, Marieke A. Vollebergh, Johannes V. van Thienen, John B. A. G. Haanen, Christian U. Blank

المصدر: Journal of Clinical Oncology. 40:9552-9552

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b5b527a802a8a40c0a14950dc932f866Test
https://doi.org/10.1200/jco.2022.40.16_suppl.9552Test

8

The interferon-gamma (IFN-y) signature from baseline tumor material predicts pathologic response after neoadjuvant ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma

المؤلفون: Irene L.M. Reijers, Petros Dimitriadis, Elisa A. Rozeman, Oscar Krijgsman, Sten Cornelissen, Linda J.W. Bosch, Annegien Broeks, Alexander M. Menzies, Bart A. van de Wiel, Richard A. Scolyer, Georgina V. Long, Christian U. Blank

المصدر: Journal of Clinical Oncology. 40:9539-9539

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::04fb3d58d7e11390d56f84269c6b20fdTest
https://doi.org/10.1200/jco.2022.40.16_suppl.9539Test

9

Survival data of PRADO: A phase 2 study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma

المصدر: Journal of Clinical Oncology. 40:9501-9501

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8843176c39d255bd642a43a9ed4b34aeTest
https://doi.org/10.1200/jco.2022.40.16_suppl.9501Test

10

Survival update of neoadjuvant ipilimumab + nivolumab in macroscopic stage III melanoma: The OpACIN and OpACIN-neo trials

المؤلفون: Judith M. Versluis, Karolina Sikorska, Elisa A. Rozeman, Alexander M. Menzies, Hanna Eriksson, W. Martin. C. Klop, Robyn P.M. Saw, Bart A. van de Wiel, Richard A. Scolyer, Johannes V. van Thienen, Henk Mallo, Maria Gonzalez, Alex Torres Acosta, Lindsay G. Grijpink-Ongering, Anja van der Wal, John B. A. G. Haanen, Alexander Christopher Jonathan Van Akkooi, Georgina V. Long, Christian U. Blank

المصدر: Journal of Clinical Oncology. 40:9572-9572

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0d5e7151c17ce46aa17b086293bde1b7Test
https://doi.org/10.1200/jco.2022.40.16_suppl.9572Test

تنقيح النتائج